|
8.30 - 8.50: To gather together (coffee and viennoiseries will be served)
8.50 - 9.00: Professor Paula Videira Welcome and introduction
Topic 1 - Rare diseases from the clinician perspective
Chaired by Doctor Vanessa Ferreira and Doctor Salomé de Almeida
9.00 - 9.40: Professor Jaak Jaeken (Keynote speaker)
“‘Congenital Diseases of Glycosylation: an exercise in dysmorphology’”
9.40 - 10.10: Doctor Luís Nunes/Doctor Salomé de Almeida
“Genetic diagnostic in rare diseases”
10.10 - 10.40: Doctor Luís Brito Avô
“Metabolic rare disease in the adults”
Topic 2 - Rare diseases from the basic research perspective
Chaired by Professor Paula Videira and Doctor Salomé de Almeida
10.40 - 10.50: Professor Paula Videira
“From cell to patients: The need for translation”
10.50 - 11.00: Doctor Cláudio M. Gomes
"Protein misfolding and rare metabolic diseases: from proteins, to drugs and organisms"
11.00 - 11.30: Discussion (coffee and viennoiseries will be served)
11.30 - 11.45: Doctor Sara Maia/Professor Miguel Seabra
“Choroideremia from bench to bedside”
11.45 - 12.00: Professor Amélia Pilar Rauter
“Drug design for rare diseases: challenges”
Topic 3 - Rare diseases from Community Association perspectives
Chaired by Professor Jaak Jaeken
12.00 - 12.25: Doctor Vanessa Ferreira
“The role of the Portuguese Association for CDG and other Rare Metabolic Disorders in the Biomedical research”
Topic 4 – Information and Communication
Chaired by Doctor Vanessa Ferreira and Professor Paula Videira
12.25 - 12.45: Marta Campabadal
“Connecting Rare Disease Patients Globally – RareConnect”, EURORDIS
12.45 - 13.10: Doctor Sandra Peixoto
“ORPHANET-PT – the reference database for rare diseases and orphan drugs in Portugal “
13.10 - 15.00: Lunch and Round table discussion will be open (lunch is available)
Round table – Putting all together, moderated by the organizers
Topics:
· How to improve relationships between science and society.
· Contribution to increase awareness of different aspects of rare diseases.
· How to improve better articulation between innovative therapies and the healthcare system.
· Information and communication – Where is the disease and patient’s information; how to keep informed; how to be connected; the contribution from ORPHANET and EURORDIS.
15.00: Distribution of certificates of attendance
|